SCIENCE THROUGH NETWORKING

EVENTI ATMP FORUM

EVENTI CONSIGLIATI

12-15 Mag, 2021
Portland, USA

AMERICAN SOCIETY OF GENE AND CELL THERAPY (ASGCT) 24TH ANNUAL MEETING

Visualizza tutti >>

Regolatorio

In questa sezione è riportato l’archivio completo delle notizie sulle ATMP, suddivise per area di interesse

Regolatorio

Business

Pricing

Clinica

Altro

REPORT ON CAR T-CELL THERAPY REGISTRIES

Data: 15 Mag, 2018

Fonte: “http://www.ema.europa.eu”

KYMRIAH® (TISAGENLECLEUCEL), FIRST-IN-CLASS CAR-T THERAPY FROM NOVARTIS, RECEIVES SECOND FDA APPROVAL TO TREAT APPROPRIATE R/R PATIENTS WITH LARGE B-CELL LYMPHOMA

Data: 1 Mag, 2018

Fonte: "https://www.novartis.com"

MALATTIE RARE DELL'OCCHIO, NOVARTIS OTTIENE LA LICENZA DI LUXTURNA FUORI DAGLI USA

Data: 26 Gen, 2018

Fonte: "https://www.pharmastar.it"

PROCEDURAL ADVICE ON THE EVALUATION OF ADVANCED THERAPY MEDICINAL PRODUCT IN ACCORDANCE WITH ARTICLE 8 OF REGULATION (EC) NO 1394/2007

Data: 25 Gen, 2018

Fonte: "http://www.ema.europa.eu"

GUIDELINE ON SAFETY AND EFFICACY FOLLOW-UP AND RISK 6 MANAGEMENT OF ADVANCED THERAPY MEDICINAL PRODUCTS

Data: 25 Gen, 2018

Fonte: "http://www.ema.europa.eu"

GUIDELINES ON GOOD MANUFACTURING PRACTICE SPECIFIC TO ADVANCED THERAPY MEDICINAL PRODUCTS- EUDRALEX VOLUME 4

Data: 22 Nov, 2017

Fonte: "https://ec.europa.eu"

FDA APPROVES PILL WITH SENSOR TO SEND INFORMATION TO DOCTOR

Data: 15 Nov, 2017

Fonte: "http://www.wbur.org/"

NICE APPROVES NOVEL GSK GENE THERAPY

Data: 23 Ott, 2017

Fonte: "https://www.nice.org.uk"

FDA APPROVES SECOND GENE-ALTERING TREATMENT FOR CANCER

Data: 18 Ott, 2017

Fonte: "https://www.nytimes.com/"

FDA PANEL UNANIMOUSLY VOTES TO APPROVE GENE THERAPY FOR BLINDNESS

Data: 12 Ott, 2017

Fonte: "https://http://edition.cnn.com/"

CAR-T: NEW FRONTIERS OF MEDICINE BETWEEN INNOVATION AND SUSTAINABILITY

Data: 4 Ott, 2017

Fonte: "http://www.agenziafarmaco.gov.it"

NOVARTIS OBTAINS FDA APPROVAL OF THE FIRST CAR-T THERAPY

Data: 30 Ago, 2017

Fonte: "https://www.fda.gov"

SPARK THERAPEUTICS SUBMITS MARKETING AUTHORIZATION APPLICATION TO EUROPEAN MEDICINES AGENCY FOR INVESTIGATIONAL LUXTURNA™ (VORETIGENE NEPARVOVEC)

Data: 31 Lug, 2017

Fonte: "http://ir.sparktx.com"

CHIESI ANNOUNCES GLYBERA WITHDRAWAL

Data: 20 Apr, 2017

Fonte: "http://www.chiesigroup.com"

GSK OBTAINS EMA APPROVAL FOR THE FIRST GENE THERAPY

Data: 1 Apr, 2016

Fonte: "http://www.ema.europa.eu"

Inizio
Indietro
1
2
3
4
5
6
Avanti
Fine

Pagina 6 di 6

Con il supporto incondizionato di

©MA Provider SRL - Via Vincenzo Monti, 3 - 20123 Milano - P.IVA 07135170962 - REA: MI-1938 161 ITALY | Info: atmp@maprovider.com

I cookie ci aiutano a fornire i nostri servizi. Utilizzando tali servizi, accetti l'utilizzo dei cookie da parte nostra